Patents Assigned to PLEX PHARMACEUTICALS, INC.
  • Dual acting FKBP12 and FKBP52 inhibitors
    Patent number: 12371406
    Abstract: Provided are novel compounds of Formulas (I) and (II), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful as dual FKBP12/FKABP inhibitors. Also provided are pharmaceutical compositions comprising the novel compounds of Formulas (I) and (II) and their use in treating Parkinson's disease.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: July 29, 2025
    Assignee: Plex Pharmaceuticals, Inc.
    Inventors: Surya Kanta De, Sridhar G. Prasad, Marshall C. Peterman
  • Dual acting FKBP12 and FKBP52 inhibitors
    Patent number: 12065407
    Abstract: Provided are novel compounds of Formulas (I) and (II), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful as dual FKBP12/FKABP inhibitors. Also provided are pharmaceutical compositions comprising the novel compounds of Formulas (I) and (II) and their use in treating Parkinson's disease.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: August 20, 2024
    Assignee: PLEX PHARMACEUTICALS, INC.
    Inventors: Surya Kanta De, Sridhar G. Prasad, Marshall C. Peterman